Pyramid Biosciences Names Nushmia Khokhar, MD, as Chief Medical Officer
Pyramid Biosciences, Inc., a Boston-based, clinical-stage biotechnology company focused on developing new and highly differentiated precision therapies for cancer and other serious diseases, today announced the expansion of its senior leadership team. Nushmia Khokhar, MD has joined the company as Chief Medical Officer, where she will oversee the advancement and expansion of the Company’s clinical pipeline. “Dr. Khokhar has a proven track record of successfully bringing novel oncology compounds through clinical development to global approval,” said CEO of Pyramid Biosciences, Brian Lestini, MD, PhD. “We are looking forward to Dr. Khokhar’s leadership of our clinical programs during this important growth stage of our company.” Read more >>